- Home
- MODV vs ONCY Comparison
MODV vs ONCY Comparison
Compare MODV & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- ONCY
- Stock Information
- Founded
- MODV 1996
- ONCY 1998
- Country
- MODV United States
- ONCY Canada
- Employees
- MODV N/A
- ONCY N/A
- Industry
- MODV Transportation Services
- ONCY Pharmaceuticals and Biotechnology
- Sector
- MODV Consumer Discretionary
- ONCY Health Care
- Exchange
- MODV Nasdaq
- ONCY Nasdaq
- Market Cap
- MODV 48.9M
- ONCY 49.1M
- IPO Year
- MODV N/A
- ONCY 1999
- Fundamental
- Price
- MODV $3.32
- ONCY $1.17
- Analyst Decision
- MODV Buy
- ONCY Strong Buy
- Analyst Count
- MODV 4
- ONCY 4
- Target Price
- MODV $9.17
- ONCY $4.33
- AVG Volume (30 Days)
- MODV 1.1M
- ONCY 1.6M
- Earning Date
- MODV 08-06-2025
- ONCY 07-31-2025
- Dividend Yield
- MODV N/A
- ONCY N/A
- EPS Growth
- MODV N/A
- ONCY N/A
- EPS
- MODV N/A
- ONCY N/A
- Revenue
- MODV $2,753,789,000.00
- ONCY N/A
- Revenue This Year
- MODV N/A
- ONCY N/A
- Revenue Next Year
- MODV $4.90
- ONCY N/A
- P/E Ratio
- MODV N/A
- ONCY N/A
- Revenue Growth
- MODV N/A
- ONCY N/A
- 52 Week Low
- MODV $0.87
- ONCY $0.33
- 52 Week High
- MODV $32.82
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- MODV 59.45
- ONCY 75.27
- Support Level
- MODV $3.01
- ONCY $0.71
- Resistance Level
- MODV $3.74
- ONCY $1.31
- Average True Range (ATR)
- MODV 0.43
- ONCY 0.12
- MACD
- MODV -0.01
- ONCY 0.04
- Stochastic Oscillator
- MODV 60.58
- ONCY 81.33
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.